| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 58,871 | 77,094 | ||
| Prepaid expenses | 1,212 | 1,521 | ||
| Restricted cash | 1,711 | 1,969 | ||
| Other current assets | 364 | 972 | ||
| Total current assets | 62,158 | 81,556 | ||
| Subtotal | 32,802 | - | ||
| Less accumulated depreciation | 32,336 | - | ||
| Restricted cash | - | 0 | ||
| Property and equipment, net | 466 | 1,638 | ||
| Right-of-use assets | 3,134 | 4,361 | ||
| Total assets | 65,758 | 87,555 | ||
| Accrued expenses | 6,790 | 20,224 | ||
| Operating lease liabilities-short-term | 3,505 | 5,007 | ||
| Accounts payable | - | 3,142 | ||
| Other current liabilities | 235 | 45 | ||
| Total current liabilities | 10,530 | 28,418 | ||
| Operating lease liabilities-long-term | 42 | 166 | ||
| Other liabilities | 0 | 188 | ||
| Total liabilities | 10,572 | 28,772 | ||
| Ordinary shares, nominal value 0.01 450,000,000 ordinary shares authorized at september 30, 2025 and december 31, 2024 17,324,771 and 17,095,371 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 174 | 173 | ||
| Additional paid-in capital | 299,208 | 299,100 | ||
| Accumulated deficit | -244,196 | -240,490 | ||
| Total equity | 55,186 | 58,783 | ||
| Total liabilities and equity | 65,758 | 87,555 | ||
Mural Oncology plc (MURA)
Mural Oncology plc (MURA)